Center for Studies on New Religions’ Bitter Winter Publishes Statement by Religious Freedom and Human Rights Organizations On Japanese Government’s Undemocratic Request to Dissolve a Minority Religion
October 14, 2023 10:33 ET
|
Center for Studies on New Religions, "Bitter Winter"
Washington, DC, Oct. 14, 2023 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Center for Studies on New Religions’ Bitter WinterPublishes Statement by Religious Freedom and Human Rights...
Center for Studies on New Religions’ Bitter Winter Publishes Statement by Religious Freedom and Human Rights Organizations On Japanese Government’s Undemocratic Request to Dissolve a Minority Religion
October 14, 2023 10:32 ET
|
Center for Studies on New Religions, "Bitter Winter"
Washington, DC, Oct. 14, 2023 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Center for Studies on New Religions’ Bitter WinterPublishes Statement by Religious Freedom and Human Rights...
Center for Studies on New Religions’ Bitter Winter Publishes Statement by Religious Freedom and Human Rights Organizations On Japanese Government’s Undemocratic Request to Dissolve a Minority Religion
October 14, 2023 05:41 ET
|
Center for Studies on New Religions, "Bitter Winter"
Washington, DC, Oct. 14, 2023 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Center for Studies on New Religions’ Bitter WinterPublishes Statement by Religious Freedom and Human Rights...
Japanese Rock Legend and Philanthropist YOSHIKI Named JAPAN HOUSE Los Angeles Advisor
August 01, 2023 12:06 ET
|
JAPAN HOUSE Los Angeles
LOS ANGELES, Aug. 01, 2023 (GLOBE NEWSWIRE) -- JAPAN HOUSE Los Angeles – part of a worldwide project conceived by the Ministry of Foreign Affairs of Japan – proudly announces that world renowned...
Mesoblast Partner JCR Pharmaceuticals Receives Recommendation For Approval Of Mesenchymal Stem Cell Product In Japan
September 03, 2015 20:44 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today announced that the allogeneic mesenchymal stem cell-based regenerative medicine...
New Japanese Regenerative Medicine Legislation and Commercial Opportunities for Stem Cell Products
November 24, 2013 19:16 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 25, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today gave an update on new legislation which provides a...